Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-13-000170
Filing Date
2013-02-07
Accepted
2013-02-07 16:20:56
Documents
1
Period of Report
2013-02-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 14607
  Complete submission text file 0000904454-13-000170.txt   16753
Mailing Address 250, NORTH BRIDGE ROAD #20-02 RAFFLES CITY TOWER SINGAPORE U0 179101
Business Address 250, NORTH BRIDGE ROAD #20-02 RAFFLES CITY TOWER SINGAPORE U0 179101 65-6832-6832
SINGAPORE BIO INNOVATIONS PTE LTD (Reporting) CIK: 0000922386 (see all company filings)

State of Incorp.: U0 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 13582727

Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20 BIOPOLIS WAY #09-01 CENTROS U0 138668
Business Address 20 BIOPOLIS WAY #09-01 CENTROS U0 138668 65 6395 7700
EDB Investments Pte Ltd. (Reporting) CIK: 0001358187 (see all company filings)

State of Incorp.: U0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 13582726